FDA panel backs new labels for osteoporosis drugs - BusinessWeek

[INCIID News Feed]

Kansas City Star
<img alt="" height="1" width="1" />
FDA panel backs new labels for osteoporosis drugs
BusinessWeek
Food and Drug Administration advisers voted Friday to require makers of widely used osteoporosis drugs to clarify how long patients should take them for the greatest benefit and least risk. The FDA itself will later decide what the ...
FDA Panel: Osteoporosis Drugs Need Better LabelsWebMD
Stronger Cautions Backed on Bone Drugs for WomenNew York Times
FDA Panel Waffles on Limiting Duration of Bisphosphonate UseABC News
Bloomberg -Reuters -MedPage Today
all 282 news articles &raquo;


More...